No Data
No Data
Most Shareholders Will Probably Agree With Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) CEO Compensation
Key Insights Tarsus Pharmaceuticals' Annual General Meeting to take place on 13th of June Salary of US$619.5k is part of CEO Bobby Azamian's total remuneration The overall pay is 49% below the ind
Tarsus to Participate in Upcoming Investor Conferences
IRVINE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersTevogen Bio Holdings (NASDAQ:TVGN) stock rose 55.4% to $1.53 during Monday's pre-market session. The market value of their outstanding shares is at $251.8 million. MiNK Therapeutics (NASDAQ:INK
Analysts Are Betting On Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) With A Big Upgrade This Week
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The analysts have sharply increased
Express News | Tarsus Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $61 From $57
Express News | Tarsus Pharmaceuticals Inc : Jefferies Raises Target Price to $48 From $46